PRESS RELEASE published on 02/07/2024 at 07:30, 2 years ago Just – Evotec Biologics expands development and manufacturing agreement with ABL for broadly neutralising antibodies against HIV Evotec SE expands partnership with ABL to develop and manufacture broadly neutralising antibodies against HIV, funded by NIAID. The collaboration aims to supply clinical material for ongoing global trials Evotec SE ABL Broadly Neutralising Antibodies HIV NIAID
PRESS RELEASE published on 01/22/2024 at 07:30, 2 years ago Evotec SE: Invitation to Conference Call Evotec SE is going to hold a conference call to provide a statement and a business update on January 22, 2024, featuring the Chairwoman of Evotec's Supervisory Board and Evotec's CEO. The call will cover the Company's commitment to compliance with Corporate Governance standards and transparent communication, as well as the execution of its existing strategy and recent market developments. For more details, including webcast access and conference call registration, please visit the provided links. Conference Call Business Update Evotec SE Corporate Governance Market Developments
PRESS RELEASE published on 11/08/2023 at 07:00, 2 years 3 months ago Evotec SE reports results for the first nine months 2023 and provides corporate update
PRESS RELEASE published on 11/07/2023 at 07:30, 2 years 3 months ago Evotec and Dewpoint Therapeutics enter strategic partnership in oncology
PRESS RELEASE published on 11/01/2023 at 12:05, 2 years 3 months ago Evotec SE to announce results for the first nine months 2023 on 08 November 2023
PRESS RELEASE published on 10/05/2023 at 07:30, 2 years 4 months ago Evotec, ClavystBio, Leaps by Bayer, Lightstone Ventures and Polaris Partners launch '65LAB'
PRESS RELEASE published on 09/27/2023 at 07:30, 2 years 4 months ago Evotec SE: Launch of partnering agreement to strengthen biotech innovators in shared R&D economy
PRESS RELEASE published on 09/26/2023 at 13:35, 2 years 4 months ago Evotec and Novo Nordisk launch LAB eN² to accelerate translation in cardiometabolic diseases
PRESS RELEASE published on 08/29/2023 at 07:00, 2 years 5 months ago Evotec SE reports results for the first half-year 2023 and provides corporate updates
PRESS RELEASE published on 08/22/2023 at 14:00, 2 years 5 months ago Evotec SE reports first half-year 2023 results on 29 August 2023
Published on 02/08/2026 at 21:00, 1 hour 56 minutes ago Banyan Gold Extends Airstrip and High-Grade Mineralization to 350m Vertical Depth, Yukon, Canada
Published on 02/07/2026 at 01:00, 1 day 21 hours ago Green Bridge Metals Can Help Secure U.S. Production of Critical Mineral Titanium
Published on 02/06/2026 at 23:10, 1 day 23 hours ago Topline Capital Management, LLC Announces Disposition of Shares of NamSys Inc.
Published on 02/06/2026 at 22:01, 2 days ago Totec Resources Announces Listing of Shares on the Frankfurt Stock Exchange and Adoption of Omnibus Incentive Plan
Published on 02/06/2026 at 15:30, 2 days 7 hours ago Vulcan Minerals Inc. - Drilling Program Update for the Carbonear Zinc-Lead SEDEX project in Newfoundland
Published on 02/07/2026 at 21:00, 1 day 1 hour ago Alibaba Group Debuts 'Wonder on Ice,' an Immersive AI Experience at Milan’s Sforza Castle for Milano Cortina 2026
Published on 02/07/2026 at 16:35, 1 day 6 hours ago The Ministry of Finance and the International Monetary Fund to launch tomorrow the second edition of the AlUla Conference for Emerging Market Economies
Published on 02/07/2026 at 16:20, 1 day 6 hours ago NOTICE OF SETTLEMENT APPROVAL HEARING - SHORT FORM - WAYLAND GROUP CORP., SCOTT LANGILLE, GERHARD MÜLLER, PAUL PATHAK, ERIC SILVER, MICHAEL STEIN, JOHN DOES 1-3, CANACCORD GENUITY CORP., AND RF SECURITIES CLEARING LP (FORMERLY KNOWN AS GMP SECU
Published on 02/06/2026 at 19:25, 2 days 3 hours ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/06/2026 at 17:52, 2 days 5 hours ago EQS-Adhoc: Avemio AG: Preparation of the filing for insolvency proceedings by Teltec AG, a subsidiary of Avemio AG, and potential effects on the going-concern assessment of Avemio AG
Published on 02/06/2026 at 18:22, 2 days 4 hours ago Disclosure of Share Capital and Voting Rights as of January 31, 2026
Published on 02/06/2026 at 16:01, 2 days 6 hours ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010093328
Published on 02/05/2026 at 18:06, 3 days 4 hours ago Aéroports de Paris SA - Shares and voting rights as of 31 January 2026